Journal of Cardiac Failure

Papers
(The H4-Index of Journal of Cardiac Failure is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Outcomes Of Hospitalization In Patients With Diastolic Heart Failure Undergoing Hematopoietic Stem Cell Transplant (HSCT): A National Inpatient Sample Analysis (2002-2019)481
Electrolyte Variability During Acute Decompensated Heart Failure Hospitalization293
Efficacy And Safety Of Intravenous Iron In Patients With Iron Deficiency Anemia And Heart Failure With Reduced Ejection Fraction. A Systematic Review And Meta-analysis167
Weight Loss Management By A Pharmacist To Overcome Obesity As A Barrier To Surgical Advanced Heart Failure Interventions134
Proteomic Correlates Of Urinary Protein Creatinine Ratio In Heart Failure With Preserved Ejection Fraction129
Psoas Muscle Index As An Independent Risk Factor Predictive Of Increased Post Operative Length Of Stay In Orthotopic Heart Transplant Candidates117
Prognostic Value Of Percentage Of Predicted Peak Oxygen Consumption Using Functional Aerobic Impairment And Friend Equations In Patients With Heart Failure With Reduced Ejection Fraction82
Effect Of Mavacamten On Echocardiographic Parameters In Patients With Obstructive Hypertrophic Cardiomyopathy: A Real World Cohort79
Readmission Rate And Hospitalization Costs In HFpEF In Patients With OSA79
Methodological Quality Of Clinical Practice Guidelines In Heart Failure: A Systematic Critical Appraisal Using The Agree II Tool64
Synchronized Diaphragmatic Stimulation As A Potential Outpatient Implant Procedure For HfrEF Therapy59
A Resident-led Initiative To Improve Heart Failure Readmission Rate By Targeting Factors Of Social Vulnerability54
Heartfelt Advances: ACC 2024 Clinical Trials Spotlight—New Horizons in Heart Failure Management53
JCF Heart Failure Year-In-Review 2023… Shaping the Future of Heart Failure51
Association of Amiodarone Use Prior to Orthotopic Heart Transplant with Post-Transplant Graft Dysfunction and All-Cause Mortality: A Systematic Review and Meta-Analysis48
Improving ATTR-CM Detection: Targeting Populations With the Greatest Need48
From Inflammation to Inspiration and Innovation: A New Perspective on the Utility of Anti-inflammatory Therapies for Acute Heart Failure48
Higher ECMO Flow Index And Hyperoxia Are Associated With Increased Mortality In Adults With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: An ELSO Registry Analysis47
Development And Implementation Of An Rv Stress Test To Assess Rv Reserve Pre-lvad45
Masthead45
Hemodynamic Response after Intra-aortic Balloon Counter-Pulsation in Cardiac Amyloidosis and Cardiogenic Shock44
The Swan is not the Ugly Duckling41
COUNTERPOINT: Abandon or Reassess? Interpreting Treatment Effects in “Negative” Clinical Trials41
Younger Adults Have Discordant Heart Failure Symptoms39
Durable Mechanical Circulatory Support: The Spring of Hope or the Winter of Despair?38
Cardiovascular Interplay Between Heart Failure Patients With Concurrent Depression, A Comprehensive Retrospective Analysis37
PHOSPHOPROTEOMIC INSIGHTS INTO PATHOBIOLOGY AND POTENTIAL DRUG TARGETS IN A PORCINE MODEL OF EXPERIMENTALLY INDUCED PULMONARY VENOUS HYPERTENSION37
QT Interval Correction In Left Bundle Branch Areas Pacing (LBBAP)37
Ventricular Assisted Device In Transposition Of Great Arteries: Indications, Outcomes, Hemodynamic Insights36
Outcomes In Patients With Right Ventricular Failure & Preserved Left Ventricular Systolic Function On Short-term Inotropic Support36
Association Of Amiodarone With Rvf Post Lvad35
Cardiac Magnetic Resonance In Patients With Suspectedtachycardia-induced Cardiomyopathy - The Impact Of Lategadolinium Enhancement And Epicardial Fat Tissue35
Emerging Adults: a Group Caught in the Middle34
The Impact Of Altitude Changes On CardioMEMS Readings33
Who wants the middle seat?: HFmrEF in a world dominated by HFpEF and HFrEF33
Novel FIRE1 Inferior Vena Cava Sensor Effective In Tracking And Managing Fluid Shifts In A Heart Failure Patient33
0.11038994789124